Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Operating Expenses | 26,613 | 17,455 | 16,759 | 17,310 | 10,773 |
| Operating Income | -26,613 | -17,455 | -16,759 | -17,310 | -10,773 |
| Interest Expense | 752 | 756 | 751 | 728 | 563 |
| Other Income | 2,767 | 2,931 | 3,333 | 3,075 | 595 |
| Pre-tax Income | -24,598 | -15,280 | -14,177 | -14,963 | -10,741 |
| Income Tax | 18 | 19 | -29 | 21 | -30 |
| Net Income Continuous | -24,616 | -15,299 | -14,148 | -14,984 | -10,711 |
| Net Income | $-24,616 | $-15,299 | $-14,148 | $-14,984 | $-10,711 |
| EPS Basic Total Ops | -0.48 | -0.30 | -0.32 | -0.38 | -0.46 |
| EPS Basic Continuous Ops | -0.48 | -0.30 | -0.32 | -0.38 | -0.46 |
| EPS Diluted Total Ops | -0.48 | -0.30 | -0.32 | -0.38 | -0.46 |
| EPS Diluted Continuous Ops | -0.48 | -0.30 | -0.32 | -0.38 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.34 | -0.32 | N/A | N/A |
| EBITDA(a) | $-27,293 | $-17,604 | $-16,677 | $-17,232 | $-10,693 |